Shape memory polymer intraocular lenses
US-9427493-B2 · Aug 30, 2016 · US
US10272176B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10272176-B2 |
| Application number | US-201615157141-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 17, 2016 |
| Priority date | Mar 7, 2011 |
| Publication date | Apr 30, 2019 |
| Grant date | Apr 30, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A shape memory polymer (SMP) intraocular lens may have a refractive index above 1.45, a Tg between 10° C. and 60° C., inclusive, de minimis or an absence of glistening, and substantially 100% transmissivity of light in the visible spectrum. The intraocular lens is then rolled at a temperature above Tg of the SMP material. The intraocular device is radially compressed within a die to a diameter of less than or equal to 1.8 mm while maintaining the temperature above Tg. The compressed intraocular lens device may be inserted through an incision less than 2 mm wide in a cornea or sclera or other anatomical structure. The lens can be inserted into the capsular bag, the ciliary sulcus, or other cavity through the incision. The SMP can substantially achieve refractive index values of greater than or equal to 1.45
Opening claim text (preview).
What is claimed is: 1. A method of manufacturing an intraocular device comprising; providing a shape memory polymer (SMP) material with a Tg; forming the SMP material in a permanent intraocular device form; mechanically compressing the intraocular device at a temperature above the Tg to deform the intraocular device into a smaller volume; and cooling the deformed intraocular device while still in compression to a temperature below the Tg to thereby create a stable deformed intraocular device with a delivery profile allowing for insertion through an incision of 2 mm or less, wherein the SMP material comprises a tert-butyl acrylate monomer and 10 wt % to 50 wt % of a poly(ethylene glycol) dimethacrylate cross-linking polymer with a molecular weight substantially between 500 and 2000, inclusive. 2. The method of claim 1 , wherein the forming operation further comprises cast molding the SMP material into the permanent intraocular device form. 3. The method of claim 2 , further comprising oversizing a mold by 0.1-20% of a desired final size of the permanent intraocular device form to account for volume shrinkage that may occur during a polymerization process of the SMP material in the cast molding operation. 4. The method of claim 1 , wherein the forming operation further comprises liquid injection molding the SMP material into the permanent intraocular device form. 5. The method of claim 4 , further comprising utilizing ultra-high pressures during the liquid injection molding operation to minimize volume shrinkage during polymerization. 6. The method of claim 1 , wherein the forming operation further comprises cryolathing the SMP material into the permanent intraocular device form. 7. The method of claim 1 , wherein the delivery profile of the deformed intraocular device is configured to fit within an incision less than or equal to 1.8 mm wide. 8. The method of claim 1 further comprising: rolling the intraocular device at a temperature above the Tg of the SMP material; and radially compressing the intraocular device within a die to a diameter of less than or equal to 1.8 mm while maintaining the temperature above the Tg. 9. The method of claim 1 further comprising packaging the deformed intraocular device for storage at or above room temperature. 10. The method of claim 1 , wherein the intraocular device is an intraocular lens. 11. The method of claim 1 , wherein the intraocular device is an intracorneal implant. 12. The method of claim 1 , wherein the Tg of the SMP material is between 10° C. and 60° C. 13. The method of claim 1 , wherein the Tg of the SMP material is greater than or equal to human body temperature. 14. The method of claim 1 , wherein the intraocular device once implanted and reformed exhibits greater than 98 percent shape recovery from the deformed intraocular device upon reaction to an external stimulus. 15. The method of claim 14 wherein the external stimulus is heat above the Tg. 16. The method of claim 15 , wherein the Tg is substantially equal to 37° C. 17. The method of claim 14 , wherein the external stimulus is ultraviolet radiation. 18. The method of claim 14 , wherein the reaction to the external stimulus is delayed for up to 600 seconds. 19. The method of claim 14 , wherein the reaction initiates within 3 to 25 seconds. 20. The method of claim 1 , wherein the SMP material further comprises a color additive.
Methods or devices for eye surgery · CPC title
Making preforms having internal stresses, e.g. plastic memory · CPC title
Intraocular lenses · CPC title
Lens includes ultraviolet absorber · CPC title
Artificial members, protheses · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.